Locations:
Search IconSearch
August 14, 2024/Innovations

Crain’s Cleveland Business: Centerline Biomedical Looks to Change ‘Current Gold Standard’ for Endovascular Intervention

Cleveland Clinic Innovations portfolio company Centerline Biomedical’s Intra-Operative Positioning System (IOPS) aims to help clinicians visualize endovascular tools in real-time and reduce their dependence on fluoroscopy systems.

Doctor with endovascular model

The use of fluoroscopy in orthopedic procedures presents a potential health risk to surgeons due to radiation exposure, even with the use of protective equipment. Centerline Biomedical, a Cleveland Clinic Innovations med-tech portfolio company, aims to address this issue with its Intra-Operative Positioning System (IOPS). Recently receiving FDA clearance for its IOPS Viewpoint Catheter, the company's technology aims to reduce reliance on fluoroscopy systems and protect clinicians from radiation exposure.

The IOPS system, based on electromagnetic tracking, creates real-time visualization of endovascular tools, offering a safer alternative to fluoroscopy. Developed as a collaboration between former Cleveland Clinic researcher Vikash Goel and the late Dr. Roy Greenberg, the technology aims to improve visualization during endovascular interventions and reduce the health risks associated with prolonged radiation exposure for surgeons.

Centerline Biomedical's IOPS system, designed to provide real-time navigation feedback, consists of a portable cart, electromagnetic field generator, sensor interface unit, and specially designed catheters and guidewires with integrated sensors. The company has been continually improving its system based on feedback from early adopters and is set to release new hardware and software updates, with plans for further upgrades in the coming years. In addition to reducing radiation exposure, the IOPS technology has the potential to enhance efficiency in the operating room, allowing doctors to work more effectively by providing clearer visualization. With the appointment of a new Chief Financial Officer and a successful $33 million Series B equity financing round in 2022, Centerline Biomedical is poised to further advance its mission of providing a safer and more efficient alternative to fluoroscopy for orthopedic procedures.

Read the full article via Crain’s Cleveland Business.

Subscribe to Cleveland Clinic Innovations' Newsletter

Follow Cleveland Clinic Innovations on LinkedIn

Latest from the Newsroom

Illustration of digital medical records
AI-Driven Chart Review Accurately Identifies Potential Rare Disease Trial Participants in New Study
A woman stretches before exercising.
Cleveland Clinic Establishes Women’s Integrated Sports, Exercise and Research Center
Cleveland Clinic President and CEO Tom Mihaljevic, M.D., with Greater Cleveland Food Bank President & CEO Kristin Warzocha.
Cleveland Clinic Pledges $50 Million to Address Hunger
Exterior of the Miller Family Pavilion
Cleveland Clinic Ranked No. 3 Hospital in the World by Newsweek
Jerry Estep, M.D., examines a patient.
Cleveland Clinic Florida Receives $3 Million Gift to Establish Endowed Chair in Cardiovascular Medicine
Artist's rendering of new Palm Beach hospital.
Cleveland Clinic Highlights Growth and Strategic Momentum in Palm Beach County
Photo of golfer with logos
Cleveland Clinic, PGA TOUR launch long-term partnership focused on player health, performance and longevity
Infographic showing results of the 2026 Heart Month survey
Cleveland Clinic Survey Finds Americans Optimistic about Aging Well, But Many Overlook Heart Disease Risks